SBIR Phase I: Biocidal Textiles for Active Infection Control

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0711927
Agency Tracking Number: 0711927
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2007
Solicitation Year: 2006
Solicitation Topic Code: BT
Solicitation Number: NSF 06-598
Small Business Information
224 N. WASHINGTON ST., Ste 1675, HAVRE DE GRACE, MD, 21078
DUNS: 091905484
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: Y
Principal Investigator
 Nina Lamba
 (410) 939-9356
Business Contact
 Nina Lamba
Title: PhD
Phone: (410) 939-9356
Research Institution
This Small Business Innovation Research (SBIR) Phase I project aims to develop a novel antimicrobial compound to provide active infection control to textiles that will be applied as a finishing treatment. Each year, 5-10% of individuals admitted to U.S. hospitals acquire an infection during treatment. Consequences of these infections include prolonged hospital stays, increased pain and discomfort, and even death. The added healthcare costs total billions of dollars annually. The number of hospital-acquired infections is increasing, with a larger proportion caused by antibiotic-resistant bacteria. Laboratory and clinical studies have shown that bacteria can survive for weeks on items found in hospital patient rooms. Creating surfaces that are continuously biocidal will provide new methods of infection control, augmenting current practices without significantly adding to the workload of healthcare workers. In this project, the technology is intended for use on fabrics. The end product may also be applied to non-textile items (e.g., keyboards and bedrails). This Phase I project seeks to develop a finishing treatment to create textiles that kill microbes on contact. Because the biocide will be chemically attached to the fabric, migration of the antimicrobial agent into the environment will be minimized. During this research, we will attach biocides to common fabrics. Physical and microbiological characterization of the resulting fabrics will be performed. The performance of these compounds is expected to exceed currently available technologies. It is expected that strategic deployment of this technology as a complement to hand-hygiene will lead to a reduction in hospital-acquired infections. Other commercial textile applications include protective garments for military personnel and emergency responders, and fabrics for sports apparel.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government